Private Advisor Group, LLC Surface Oncology, Inc. Transaction History

Private Advisor Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	BUY	$2.65 - $5.08 $212 - $406	80 Added 0.46%	17,325 $51,000
Q3 2021 Oct 14, 2021	BUY	$5.16 - $7.98 $567 - $877	110 Added 0.64%	17,245 $131,000
Q1 2021 Apr 22, 2021	BUY	$7.25 - $13.82 $8,228 - $15,685	1,135 Added 7.09%	17,135 $134,000
Q4 2020 Apr 01, 2021	SELL	$6.87 - $10.48 $13,740 - $20,960	-2,000 Reduced 11.11%	16,000 $148,000
Q3 2020 Nov 02, 2020	BUY	$5.06 - $7.23 $91,080 - $130,140	18,000 New	18,000 $124,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.